Gene · 151306
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From Structure to Dynamics: Activation Mechanism of the G Protein-Coupled Bile Acid Receptor 1‑Gs Complex. | ACS Omega | 2026 | 42662721 | PubTator, text mining | PubMed |
| Emerging insights of bile acids in cardiovascular physiology and disease: from molecular mechanisms to therapeutic potential. | Front Pharmacol | 2026 | 42662099 | PubTator, text mining | PubMed |
| Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review. | Pharmaceuticals (Basel) | 2026 | 42653681 | PubTator, text mining | PubMed |
| Dysregulated bile acid metabolism impairs intestinal barrier integrity via defective GPBAR1 signaling in low-birth-weight suckling piglet. | Anim Nutr | 2026 | 42602664 | PubTator, text mining | PubMed |
| Natural products for depression: Preclinical insights into microbiota-gut-brain axis modulation and pharmacological potential. | Pharmacol Res | 2026 | 42595199 | PubTator, text mining | PubMed |
| Gut microbiota-immune crosstalk in childhood and adolescent obesity: mechanistic insights and therapeutic potential focused on short-chain fatty acids and emerging metabolites. | Front Microbiol | 2026 | 42591748 | PubTator, text mining | PubMed |
| Bile acids as mediators of microbiota signaling in entero-hepatic disorders. | Biochem Pharmacol | 2026 | 42580493 | PubTator, text mining | PubMed |
| Tetracyclic triterpenes from Chios Mastic Gum act as TGR5 and RORγ modulators. | Biomed Pharmacother | 2026 | 42570635 | PubTator, text mining | PubMed |
| Bile acid signaling: from dynamic pool composition to inter-organ communication. | Front Endocrinol (Lausanne) | 2026 | 42568439 | PubTator, text mining | PubMed |
| The Microbiome-Mitochondria Axis in aging: a self-reinforcing vicious cycle linking metabolic dysregulation, mitochondrial quality control failure, and inflammaging. | Front Microbiol | 2026 | 42558902 | PubTator, text mining | PubMed |
| Microbiota in cholestatic diseases: crosstalk among bile composition, the biliary microbiome, and host immunity. | Front Immunol | 2026 | 42558207 | PubTator, text mining | PubMed |
| Microbiota-innate immune crosstalk drives atherosclerosis: mechanisms, disease progression, and emerging therapeutic strategies. | Front Immunol | 2026 | 42539514 | PubTator, text mining | PubMed |
| Programmed cell death mechanisms of traditional plant medicine in prostate cancer therapy. | Front Immunol | 2026 | 42523794 | PubTator, text mining | PubMed |
| Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism. | Front Immunol | 2026 | 42519323 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Gut Microbiota-Immune System Crosstalk: From Mucosal Architecture to Adaptive Immunity Programming. | Int J Mol Sci | 2026 | 42511589 | PubTator, text mining | PubMed |
| Bile Acid Metabolism in Gout Pathogenesis from Gut-Liver-Joint Crosstalk to Therapeutic Opportunities. | Metabolites | 2026 | 42506417 | PubTator, text mining | PubMed |
| Altered bile acid metabolism in people with HIV correlates with systemic and intestinal inflammation. | AIDS | 2026 | 42504576 | PubTator, text mining | PubMed |
| Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-priming. | Signal Transduct Target Ther | 2026 | 42503514 | PubTator, text mining | PubMed |
| Gut‑liver‑kidney axis: A systems biology framework for understanding and treating chronic kidney disease (Review). | Int J Mol Med | 2026 | 42495760 | PubTator, text mining | PubMed |
| Fully Automatable Relative Binding Free Energy Calculations with Enhanced Sampling Using FAST/MBAR. | J Chem Theory Comput | 2026 | 42490053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/151306/papers?page=2